Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long‐term outcome in patients with autoimmune encephalitis
Radu Constantinescu(Sahlgrenska University Hospital), Henrik Zetterberg(National Hospital for Neurology and Neurosurgery), Lars Rosengren(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Clas Malmeström(University of Gothenburg), Filip Bergquist(Sahlgrenska University Hospital), Markus Axelsson(Sahlgrenska University Hospital), Kerstin Andrén(Sahlgrenska University Hospital), Fredrik Asztély(University of Gothenburg), Elinor Ben Menachem(Sahlgrenska University Hospital), David Krýsl(Sahlgrenska University Hospital)
Cited by 58
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k